On July 21, 2019, the Standardization Professional Committee of 3D Printing Group of China Medical Device Industry Association held a meeting in Shanghai Oriental Hospital, at which the first five 3D printing medical device group standards were officially released and implemented, and the second batch of 10 3D printing medical device group standards was launched. Dai Qilong, Academician of the Chinese Academy of Engineering, Lu Bingheng, Wang Yingjun, and Liu Bin, Minister of the Institute Examination Center of the State Food and Drug Administration, and other expert leaders attended the meeting.

The Standardization Law of the People's Republic of China, which was implemented on January 1, 2018, formally gave the group standards the legal place they should have. The lack of standards seriously hindered the development of the 3D printing and equipment industry. As Academician Wang Yingjun said, the group standards promoted by the 3D Special Committee took the lead in the world, not the translation and follow-up of foreign standards.

T-Bright Biotechnology was invited to act as the drafting unit of the group standard of 'Special Requirements for Biological 3D Printing Medical Device Production Quality Management Specifications', and will work actively with other members of the standard preparation group to complete the preparation task of the group standard within one year.

With the development and implementation of the 3D printing medical device group standard, it has filled the gap of domestic and foreign standards in this field, and will certainly accelerate the industrialization of 3D printing medical devices in China!